1Cell.Ai and BioSkryb Announce Strategic Partnership to Advance Single Cell Multi-omics Innovation

FOSTER CITY, Calif. and DURHAM, N.C. -- 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics, a pioneer in single cell multi-omics, to co-develop and commercialize next-generation single cell multi-omic solutions. This collaboration will empower researchers and clinicians to detect and characterize rare mutations in single cells with unprecedented accuracy, facilitating breakthroughs in cancer [...]

Element Biosciences Accelerates Rollout of Direct in Sample Sequencing for the AVITI24™ Intelligent Multiomics System to Meet Growing Demand

Company to present four abstracts at the American Association for Cancer Research 2025 annual meeting highlighting research from AVITI24, the Trinity™ workflow solution, and new direct in sample sequencing applications SAN DIEGO -- Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the accelerated rollout and availability of direct in [...]

Isolere Bio by Donaldson Passes Most Significant Milestone To-Date, Announces Availability of Manufacturing-Grade IsoTag™ AAV Reagent

RESEARCH TRIANGLE PARK, N.C. -- Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTag™ AAV reagent for the purification of Adeno-associated Virus (AAV) vectors. As indicated during the launch of the research-grade reagent in October 2024, this final advancement in product grade now includes production with validated processes and [...]

Syncell Launches New Preferred Partner Network Expanding Commercial Capabilities and Offering Services in Collaboration with OMAPiX and MS Bioworks

New relationships with Cold Spring Biotech, SCRUM and DaonBS in APAC will enable many more laboratories to adopt Syncell technology TAIPEI, Taiwan & LIVERMORE, Calif. -- Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, announced the launch of their preferred partner network today. The company’s commercial expansion includes new services partners [...]

EpiCypher Launches Novel, Affordable DNA Methylation Sequencing Assays to Accelerate Drug Discovery

Durham, NC – EpiCypher®, a leader in epigenomics innovation, announces the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery. These tools build upon EpiCypher’s proven CUT&RUN platform – a targeted nuclease strategy that has revolutionized chromatin profiling by enabling high-resolution mapping [...]

Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025

Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from target discovery to clinical development SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of new and enhanced [...]

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing, deep sequencing for liquid biopsy research and MRD, and methylation detection Diverse portfolio of adapter sets now includes industry leading number of unique indexes at 3,072 HT UDI Adapters Enables multiplexing and high throughput sequencing SOUTH SAN FRANCISCO, Calif. --  [...]

Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery

PORTLAND, Ore. — Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today announced the successful completion of its Seed funding round, raising $7.2 million in new equity investment and converting $4.0 million in SAFEs, bringing total financing since Araceli’s spinout from Phoseon Technology to $11.2M. This funding will accelerate Araceli’s commercial expansion, scale manufacturing, and advance its [...]

Deepcell Appoints Janette Phi as Chief Business Officer, Raises Venture Round, and Expands to New Menlo Park HQ

As momentum builds, Deepcell advances commercial scale-up and market expansion for its AI-powered single cell analysis platform.  MENLO PARK, CA – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the appointment of Janette Phi as Chief Business and Commercial Officer. The company also completed an initial closing of a [...]

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Boulder, CO – Watchmaker Genomics, a leader in high-performance genomics solutions, today announced an important milestone in providing comprehensive and robust automated solutions for next-generation sequencing (NGS) workflows. Its collaboration with Revvity has resulted in fully automated and verified methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx* liquid [...]

Access IBO on Knowledge Center